Artiva Biotherapeutics
(NASDAQ) ARTV
Artiva Biotherapeutics Financials at a Glance
Market Cap
$131.49M
Revenue (TTM)
$0.00
Net Income (TTM)
$83.86M
EPS (TTM)
$-3.43
P/E Ratio
-1.55
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$5.26
Volume
1,403
Open
$5.41
Price
$5.26
Volume
1,403
Open
$5.41
Previous Close
$5.26
Daily Range
$5.24 - $5.52
52-Week Range
$1.47 - $7.75
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$5.26
Volume
1,403
Open
$5.41
Previous Close
$5.26
Daily Range
$5.24 - $5.52
52-Week Range
$1.47 - $7.75
ARTV News
ARTV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Artiva Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
104
CEO
Fred Aslan, MD, MBA
Website
www.artivabio.comHeadquarters
San Diego, CA 92121, US
ARTV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-57%
Return on Capital
-76%
Return on Assets
-64%
Earnings Yield
-64.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$131.49M
Shares Outstanding
24.72M
Volume
1.40K
Short Interest
0.00%
Avg. Volume
191.13K
Financials (TTM)
Gross Profit
$2.60M
Operating Income
$90.61M
EBITDA
$88.01M
Operating Cash Flow
$76.75M
Capital Expenditure
$2.59M
Free Cash Flow
$79.34M
Cash & ST Invst.
$108.01M
Total Debt
$10.94M
Artiva Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$666.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$131.49M
N/A
Market Cap/Employee
$1.37M
N/A
Employees
96
N/A
Net Income
$20.77M
-125.4%
EBITDA
$21.47M
-21.6%
Quarterly Fundamentals
Net Cash
$97.07M
-43.3%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$7.88M
-25.7%
Short Term Debt
$3.06M
-18.2%
Return on Assets
-64.05%
N/A
Return on Invested Capital
-76.37%
N/A
Free Cash Flow
$15.15M
-2.9%
Operating Cash Flow
$14.73M
-0.5%